About us

Full Lifecycle Investment Platform

Why We Exist

Scientific progress increasingly moves across disciplines and expands capability throughout surrounding industries. Computation accelerates biological analysis and materials discovery while improving industrial control and system modeling. Advances in materials extend possibilities across energy and aerospace, with similar effects in medicine, manufacturing, semiconductors, and space systems. Improved sensing changes how physical and biological systems are measured and operated.

Modern science develops through specialized fields, while its economic consequences form across them. Biology increasingly draws from chemistry, computation, physics, and engineering. Materials research shapes energy systems, medical devices, industrial equipment, semiconductors, and orbital infrastructure. Artificial intelligence extends analysis across these subjects. Quantum computing introduces new approaches to molecular, chemical, material, and physical simulation as its capabilities advance.

Modern assets reflect this convergence. Mineral assets combine geology and geochemistry with extraction, energy, processing, and supporting infrastructure. Hospital and diagnostic systems join biological mechanisms with clinical practice, laboratory operations, computation, regulation, and reimbursement. Space infrastructure unites physics and materials with power, thermal management, communications, launch, and orbital operations.

SKGP operates as an integrating research and investment layer across these fields. Broad scientific understanding establishes relationships among disciplines. Specialized knowledge provides depth within each subject. Research follows scientific mechanisms into engineered systems, operating assets, industrial markets, and capital structures.

Capabilities and institutions advance at different rates. Science can move ahead of infrastructure. Technology can surpass regulation or operating practice. Demand can emerge before production and distribution. Existing infrastructure can acquire new value as higher uses become possible.

SKGP invests across gaps between capability and application. Research identifies relationships limiting performance and directs capital toward assets capable of completing a larger system. Opportunity can reside in an originating technology or within the infrastructure, manufacturing, data, distribution, and operating platforms required for deployment.

SKGP operates across the full lifecycle of assets, businesses and projects, from early development through growth, mature ownership, restructuring, and distressed situations. Early stage capital supports technical validation, project/infrastructure development, and initial commercialization. Growth and mature strategies include growth investments, acquisitions, buyouts, carve outs, structured transactions, capacity expansion, and operating improvement. Restructuring strategies address distressed assets through recapitalization, debt reorganization, changes in control, or the separation and consolidation of businesses. Research is translated into the transaction, capital structure, governance, and ownership required to develop, acquire, reposition, stabilize, retain, refinance, or realize each asset.

Investment Research

Multiscale Systems Research And Research Infrastructure

Multiscale systems Research
Each investigation begins with a defined focal system. Research moves inward to examine governing mechanisms, then outward toward material dependencies. Vertical analysis follows scientific capability into engineering and operations before reaching capital and ownership. Horizontal analysis places an asset among competing technologies, infrastructure, suppliers, customers, and adjacent fields.

Scientific breadth allows SKGP to follow a mechanism across disciplinary boundaries without losing causal precision. Molecular behavior can be traced into a diagnostic platform. Material properties can be followed into an energy or space system. Computational advances can be connected to physical production, biological analysis, and operating control.

Inputs and causes are traced through outputs and downstream effects until a controlling relationship is identified. That relationship can represent a fixed boundary, a changeable constraint, or a limit moving through scientific and technical progress. The resulting system map establishes present condition, achievable future state, required intervention, and means of ownership.

Research Infrastructure
Human Directed, Computationally Extended

SKGP operates a human directed research system supported by artificial intelligence, advanced computation, simulation, structured information, and internally developed scripts. The firm continues to develop access to emerging computational methods, including quantum capabilities as their scientific and commercial utility advances.

Scientific understanding directs the use of these systems. Knowledge across biology, chemistry, physics, materials science, mathematics, and engineering determines which questions matter, which methods apply, and how results should be interpreted. Computational capability extends the range and speed of research while human judgment maintains scientific context and investment discipline.

Artificial intelligence supports source discovery, literature review, technical comparison, and evidence synthesis. Internally developed scripts assist data extraction, relationship mapping, scenario analysis, and continued monitoring. Simulation tests how changes in one part of a system affect surrounding processes and constraints.

Quantum computing represents an emerging extension of this research capacity. Potential applications include molecular simulation, chemical processes, materials behavior, optimization, and complex physical systems. SKGP follows progress in quantum hardware, algorithms, and hybrid computing to identify where these capabilities can strengthen research or alter the productive limits of an asset.

Researchers direct each inquiry. They evaluate evidence, determine material relationships, incorporate specialist judgment, and translate findings into investment decisions.System maps preserve core assumptions, specialist conclusions, points of disagreement, and evidence produced through ownership. Completed investments deepen SKGP’s research base and sharpen future evaluation.

Scientific and Technical Research

Scientific and technical research establishes capability boundaries for an asset, product, or process. Analysis begins with governing physical laws and chemical interactions. Biological mechanisms, material properties, mathematics, and computation are examined according to the system involved.

Physical research examines geology and geochemistry alongside thermodynamics, material behavior, extraction, processing, and energy conversion. Biological research follows disease mechanisms from molecular pathways and biomarkers through clinical evidence and patient response. Engineered systems are evaluated through hardware and algorithms, with close attention to data quality, power, latency, networking, and computational limits.

Classical computation, artificial intelligence, and simulation increase the scale at which scientific evidence can be compared and modeled. Emerging quantum methods extend this capability toward problems grounded in molecular interactions, materials, chemistry, and complex physical behavior.Research defines technical possibility and identifies advances capable of changing productive or commercial potential.

Integrated Research Process

Each investment begins with a defined question and a map of the system responsible for its performance. Scientific research establishes the governing mechanism and determines whether recent advances have changed what is technically or economically possible. Evidence and specialist review distinguish a credible transition from an unsupported thesis.

Engineering translates scientific potential into a system that can be built, integrated, and maintained. Operational research determines how that system performs under commercial conditions. Optimization establishes the proper sequence of change while accounting for reliability, cost, capacity, and risk.

Industrial and commercial research place the asset within its market and trace how technical value becomes demand and revenue. Regulatory analysis establishes the permitted path and expected timeline. Financial research defines the capital required to complete the transition. Transaction structure and governance provide the ownership and authority needed to execute it.

Artificial intelligence expands discovery, comparison, synthesis, and monitoring. Advanced computation and simulation test relationships that are difficult to observe directly. Emerging quantum methods are incorporated where they offer relevant approaches to molecular systems, materials, optimization, or physical simulation. Scientific judgment governs how each tool is selected and interpreted.

Combined findings produce an investment plan defining present condition, intended operating state, binding constraint, required intervention, capital structure, and ownership horizon. Evidence produced through ownership returns to research, testing prior assumptions and strengthening future underwriting.

Integrated Specialist Network

SKGP maintains an Integrated Specialist Network through which scientific, financial, and operating expertise is applied to investments. Engagement is determined by subject matter, material uncertainty, and execution requirements.

PhD researchers, laboratory leaders, physicians, and senior engineers provide scientific depth relevant to each system. Their assessment tests underlying mechanisms, evaluates evidence, defines technical limits, and determines commercial scale. Coverage extends across established sciences and continues to deepen in artificial intelligence, quantum information science, energy, healthcare, and space systems.

Investment principals, bankers, credit professionals, and restructuring specialists provide financial and transaction experience. They define funding requirements, ownership terms, downside protection, and refinancing pathways. Transaction counsel establishes control rights and legal execution.

Operators, senior executives, project developers, and industry founders contribute direct operating judgment. Their experience informs implementation, organizational design, capacity expansion, integration, and stabilization.

Specialists are engaged by strategy, vehicle, or asset. Credentials and execution records correspond directly to the mandate supported. Involvement extends from research and underwriting through transaction execution, governance, and portfolio operations.

SKGP directs each engagement. It defines the focal question, identifies required expertise, and resolves differences in judgment. Technical conclusions establish underwriting assumptions. Operating requirements shape capital and transaction terms. Governance secures the authority required for execution.

Each mandate adds research, operating evidence, transaction knowledge, and specialist relationships to SKGP. This accumulated experience strengthens future investments and the firm’s institutional depth.

System Domains

Physical systems include
Physical systems encompass natural resources and mining, energy and industrial processing, manufacturing and logistics, transportation, land, and water. Data centers and space infrastructure extend this domain into increasingly technical assets.

Space infrastructure includes launch, satellite, orbital, power, communications, sensing, and supporting ground systems. Its development draws physical science, engineering, computation, and infrastructure into a single operating environment.

Performance emerges through geology and chemistry as well as materials, geography, and energy. Infrastructure and equipment convert those conditions into physical output. SKGP studies advances capable of changing cost, reliability, productive capacity, or strategic position.


Biological systems  
Biological systems encompass healthcare delivery, hospital and provider systems, diagnostics, and molecular testing. The domain includes clinical laboratories and imaging, then extends through specialty care, biotechnology, pharmaceuticals, research services, and manufacturing. Medical devices, health data, and disease focused platforms complete the system around patient care.

Value progresses from biological mechanism into clinical evidence and reproducible manufacturing. Hospital and provider systems translate those capabilities into clinical practice. Regulation, reimbursement, distribution, and operating performance determine broader adoption and patient impact.SKGP identifies assets capable of advancing or completing that progression.

Engineered Systems
Engineered systems encompass computation and data infrastructure, including semiconductors and software. Artificial intelligence and simulation provide analytical and modeling capability. Quantum computing extends this domain through emerging methods for scientific computation and complex system analysis.

Quantum technologies also include sensing and communications, creating applications beyond computation alone. Automation and robotics support physical execution. Telecommunications, cybersecurity, and control platforms maintain coordination across increasingly complex assets.

Engineered systems operate as independent investments and as sensing, modeling, decision, and execution layers within physical and biological systems. SKGP invests in technology alongside the infrastructure and operating platforms through which its capability is deployed.

Contact

Connect With SKGP

LP Inquiries